<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03581032</url>
  </required_header>
  <id_info>
    <org_study_id>17-13</org_study_id>
    <nct_id>NCT03581032</nct_id>
  </id_info>
  <brief_title>Optimization of Cardiac Pacing Using CardioMEMS</brief_title>
  <official_title>Optimization of Cardiac Pacing Using CardioMEMS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Francis Hospital, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Francis Hospital, New York</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine if a simplified technique for cardiac device
      reprogramming using pulmonary artery pressure (PAP) data in the acute setting holds promise
      to improve subjective assessments of patient quality of life (QOL), objective measurements of
      functional capacity, and specific systolic and diastolic echocardiographic indices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study is designed to determine if a simplified technique for cardiac device( CRT)
      reprogramming using pulmonary artery pressure (PAP) via implanted CardioMEMS device data in
      the acute setting holds promise to improve subjective assessments of patient quality of life
      (QOL), objective measurements of functional capacity, and specific systolic and diastolic
      echocardiographic indices. The protocol requires prospective collection and analysis of
      echocardiographic data, subjective symptoms (Minnesota Living with Heart Failure
      Questionnaires), and 6-minute walk distance measurements in patients with implanted
      biventricular pacemakers / defibrillators who are predominantly ventricularly paced, in
      normal sinus rhythm, have documented NYHA class 3 Heart Failure, and have implanted pulmonary
      artery pressure monitors (CardioMEMS, St. Jude Medical CRMD, St. Paul, MN). Data collection
      will occur at presentation (rest and with ambulation), one month post-reprogramming, and two
      months after evaluation and / or reprogramming.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary artery pressure changes</measure>
    <time_frame>30 days</time_frame>
    <description>Primary endpoint is changes in of pulmonary artery pressures within 30 days in patients who have optimization of pacing devices.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>A-Active reprogram follwed by sham</arm_group_label>
    <description>This arm will be randomized to have PACING device reprogramming followed by sham reprogramming</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B-Sham followed by active reprogram</arm_group_label>
    <description>This arm will be randomized to have sham reprogramming followed by active pacing reprogramming</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active reprogam</intervention_name>
    <description>Reprogram Changes in AV/PV delays</description>
    <arm_group_label>A-Active reprogram follwed by sham</arm_group_label>
    <arm_group_label>B-Sham followed by active reprogram</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subject Recruitment Subjects will be recruited from the CHF outpatient clinic at St Francis
        Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients have implanted PPM, ICD, or CRT devices and CardioMEMS

          2. Patients can ambulate for 6 minutes and lay on a flat surface

          3. Patients are paced &gt; 95% of the time

          4. Patients are not in acute CHF and are on a stable medication regimen

          5. Patients have adequate echocardiographic windows

          6. Patients can consent independently

        Exclusion Criteria:

          1. Patients with poor echocardiographic acoustical resolution.

          2. Patients with congenital heart disease.

          3. Patients with mechanical aortic or mitral valve replacements.

          4. Patients with significant mitral annular calcification.

          5. Patients with irregular heart rates: atrial fibrillation, supraventricular
             tachycardia, atrial premature contractions, and ventricular arrhythmia that would
             preclude data acquisition.

          6. Patients unable to remain still secondary to movement disorders or agitation.

          7. Inpatient status

          8. Patients with poorly controlled HTN (SBP&gt;160/90
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Rita Jermyn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Francis Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth S Haag, BSN MPA</last_name>
    <phone>516 622-4512</phone>
    <email>elizabeth.haag@chsli.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rita Jermyn, MD</last_name>
    <phone>516 562-6426</phone>
    <email>rita.jermyn@chsli.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Haag, BSN MPA</last_name>
      <phone>516-622-4512</phone>
      <email>elizabeth.haag@chsli.org</email>
    </contact>
    <contact_backup>
      <last_name>Rita Jermyn, MD</last_name>
      <phone>516 562-6646</phone>
      <email>rita.jermyn@chsli.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002 Jun 13;346(24):1845-53.</citation>
    <PMID>12063368</PMID>
  </results_reference>
  <results_reference>
    <citation>Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003 May 28;289(20):2685-94.</citation>
    <PMID>12771115</PMID>
  </results_reference>
  <results_reference>
    <citation>Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008 May 20;117(20):2608-16. doi: 10.1161/CIRCULATIONAHA.107.743120. Epub 2008 May 5.</citation>
    <PMID>18458170</PMID>
  </results_reference>
  <results_reference>
    <citation>Mullens W, Grimm RA, Verga T, Dresing T, Starling RC, Wilkoff BL, Tang WH. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009 Mar 3;53(9):765-73. doi: 10.1016/j.jacc.2008.11.024.</citation>
    <PMID>19245967</PMID>
  </results_reference>
  <results_reference>
    <citation>Birnie D, Lemke B, Aonuma K, Krum H, Lee KL, Gasparini M, Starling RC, Milasinovic G, Gorcsan J 3rd, Houmsse M, Abeyratne A, Sambelashvili A, Martin DO. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial. Heart Rhythm. 2013 Sep;10(9):1368-74. doi: 10.1016/j.hrthm.2013.07.007. Epub 2013 Jul 11.</citation>
    <PMID>23851059</PMID>
  </results_reference>
  <results_reference>
    <citation>Martin DO, Lemke B, Birnie D, Krum H, Lee KL, Aonuma K, Gasparini M, Starling RC, Milasinovic G, Rogers T, Sambelashvili A, Gorcsan J 3rd, Houmsse M; Adaptive CRT Study Investigators. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm. 2012 Nov;9(11):1807-14. doi: 10.1016/j.hrthm.2012.07.009. Epub 2012 Jul 14.</citation>
    <PMID>22796472</PMID>
  </results_reference>
  <results_reference>
    <citation>Starling RC, Krum H, Bril S, Tsintzos SI, Rogers T, Hudnall JH, Martin DO. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial. JACC Heart Fail. 2015 Jul;3(7):565-572. doi: 10.1016/j.jchf.2015.03.001. Epub 2015 Jun 10.</citation>
    <PMID>26071616</PMID>
  </results_reference>
  <results_reference>
    <citation>Galderisi M, Benjamin EJ, Evans JC, D'Agostino RB, Fuller DL, Lehman B, Wolf PA, Levy D. Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart Study). Am J Cardiol. 1992 Nov 15;70(15):1341-6.</citation>
    <PMID>1442588</PMID>
  </results_reference>
  <results_reference>
    <citation>Ritter P, Padeletti L, Gillio-Meina L, Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace. 1999 Apr;1(2):126-30.</citation>
    <PMID>11228855</PMID>
  </results_reference>
  <results_reference>
    <citation>Meluzín J, Novák M, Müllerová J, Krejcí J, Hude P, Eisenberger M, Dusek L, Dvorák I, Spinarová L. A fast and simple echocardiographic method of determination of the optimal atrioventricular delay in patients after biventricular stimulation. Pacing Clin Electrophysiol. 2004 Jan;27(1):58-64.</citation>
    <PMID>14720156</PMID>
  </results_reference>
  <results_reference>
    <citation>Kindermann M, Fröhlig G, Doerr T, Schieffer H. Optimizing the AV delay in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography. Pacing Clin Electrophysiol. 1997 Oct;20(10 Pt 1):2453-62.</citation>
    <PMID>9358487</PMID>
  </results_reference>
  <results_reference>
    <citation>Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004 Nov;1(5):562-7.</citation>
    <PMID>15851220</PMID>
  </results_reference>
  <results_reference>
    <citation>Butter C, Stellbrink C, Belalcazar A, Villalta D, Schlegl M, Sinha A, Cuesta F, Reister C. Cardiac resynchronization therapy optimization by finger plethysmography. Heart Rhythm. 2004 Nov;1(5):568-75.</citation>
    <PMID>15851221</PMID>
  </results_reference>
  <results_reference>
    <citation>Perego GB, Chianca R, Facchini M, Frattola A, Balla E, Zucchi S, Cavaglià S, Vicini I, Negretto M, Osculati G. Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study. Eur J Heart Fail. 2003 Jun;5(3):305-13.</citation>
    <PMID>12798828</PMID>
  </results_reference>
  <results_reference>
    <citation>van Gelder BM, Bracke FA, Meijer A, Lakerveld LJ, Pijls NH. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol. 2004 Jun 15;93(12):1500-3.</citation>
    <PMID>15194020</PMID>
  </results_reference>
  <results_reference>
    <citation>Yu CM, Fung JW, Zhang Q, Chan CK, Chan YS, Lin H, Kum LC, Kong SL, Zhang Y, Sanderson JE. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation. 2004 Jul 6;110(1):66-73. Epub 2004 Jun 14.</citation>
    <PMID>15197148</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee KL, Burnes JE, Mullen TJ, Hettrick DA, Tse HF, Lau CP. Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients. J Cardiovasc Electrophysiol. 2007 May;18(5):497-504. Epub 2007 Apr 11.</citation>
    <PMID>17428272</PMID>
  </results_reference>
  <results_reference>
    <citation>van Gelder BM, Bracke FA, Meijer A, Pijls NH. The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. J Am Coll Cardiol. 2005 Dec 20;46(12):2305-10.</citation>
    <PMID>16360063</PMID>
  </results_reference>
  <results_reference>
    <citation>Thibault B, Ducharme A, Harel F, White M, O'Meara E, Guertin MC, Lavoie J, Frasure-Smith N, Dubuc M, Guerra P, Macle L, Rivard L, Roy D, Talajic M, Khairy P; Evaluation of Resynchronization Therapy for Heart Failure (GREATER-EARTH) Investigators. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation. 2011 Dec 20;124(25):2874-81. doi: 10.1161/CIRCULATIONAHA.111.032904. Epub 2011 Nov 21.</citation>
    <PMID>22104549</PMID>
  </results_reference>
  <results_reference>
    <citation>Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005 Aug 9;112(6):841-8. Epub 2005 Aug 1.</citation>
    <PMID>16061743</PMID>
  </results_reference>
  <results_reference>
    <citation>Khoury DS, Naware M, Siou J, Blomqvist A, Mathuria NS, Wang J, Shih HT, Nagueh SF, Panescu D. Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. J Am Coll Cardiol. 2009 Mar 24;53(12):1075-81. doi: 10.1016/j.jacc.2008.12.018.</citation>
    <PMID>19298923</PMID>
  </results_reference>
  <results_reference>
    <citation>Maines M, Catanzariti D, Cemin C, Vaccarini C, Vergara G. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study. J Interv Card Electrophysiol. 2007 Sep;19(3):201-7. Epub 2007 Sep 6.</citation>
    <PMID>17805952</PMID>
  </results_reference>
  <results_reference>
    <citation>Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012. Epub 2009 Mar 17.</citation>
    <PMID>19643357</PMID>
  </results_reference>
  <results_reference>
    <citation>Sogaard P, Egeblad H, Pedersen AK, Kim WY, Kristensen BO, Hansen PS, Mortensen PT. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation. 2002 Oct 15;106(16):2078-84.</citation>
    <PMID>12379577</PMID>
  </results_reference>
  <results_reference>
    <citation>Søgaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BØ, Mortensen PT. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol. 2002 Aug 21;40(4):723-30.</citation>
    <PMID>12204503</PMID>
  </results_reference>
  <results_reference>
    <citation>Haugaa KH, Marek JJ, Ahmed M, Ryo K, Adelstein EC, Schwartzman D, Saba S, Gorcsan J 3rd. Mechanical dyssynchrony after cardiac resynchronization therapy for severely symptomatic heart failure is associated with risk for ventricular arrhythmias. J Am Soc Echocardiogr. 2014 Aug;27(8):872-9. doi: 10.1016/j.echo.2014.04.001. Epub 2014 May 3.</citation>
    <PMID>24798865</PMID>
  </results_reference>
  <results_reference>
    <citation>Papadopoulou E, Kaladaridou A, Mattheou J, Pamboucas C, Hatzidou S, Antoniou A, Toumanidis S. Effect of pacing mode and pacing site on torsional and strain parameters and on coronary flow. J Am Soc Echocardiogr. 2015 Mar;28(3):347-54. doi: 10.1016/j.echo.2014.10.014. Epub 2014 Nov 26.</citation>
    <PMID>25456534</PMID>
  </results_reference>
  <results_reference>
    <citation>Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011 Feb 19;377(9766):658-66. doi: 10.1016/S0140-6736(11)60101-3. Erratum in: Lancet. 2012 Feb 4;379(9814):412.</citation>
    <PMID>21315441</PMID>
  </results_reference>
  <results_reference>
    <citation>Pappone C, Augello G, Rosanio S, Vicedomini G, Santinelli V, Romano M, Agricola E, Maggi F, Buchmayr G, Moretti G, Mika Y, Ben-Haim SA, Wolzt M, Stix G, Schmidinger H. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol. 2004 Apr;15(4):418-27.</citation>
    <PMID>15089990</PMID>
  </results_reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>May 25, 2018</study_first_submitted>
  <study_first_submitted_qc>July 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 10, 2018</study_first_posted>
  <last_update_submitted>July 6, 2018</last_update_submitted>
  <last_update_submitted_qc>July 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Francis Hospital, New York</investigator_affiliation>
    <investigator_full_name>Rita Jermyn, MD</investigator_full_name>
    <investigator_title>Director of Center for Cardiac Therapeutics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

